Rozart
Natural health product licensed in Canada
- Other names
- Rose Hip Extract, Rose Hip Tablets
- Licence holder
- Elbon Wellbeing Canada Inc.
- NPN or DIN-HM
- 80062938
- Status
- Active licence
- Licence date
- 23 July 2015
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rosa canina Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 3,200 mg | 800 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium colloïdal, Croscarmellose de sodium, Hypromellose, Glycérol, Dioxyde de titane, Talc, Cellulose microcristalline, Oxyde de fer (Fe2O3), Stéarate de magnésium, Povidone K-30, Phosphate dicalcique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of antioxidants. Provides antioxidants that help protect against the oxidative damage caused by free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80062938
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.